Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THSD1P1 (Thrombospondin type 1 domain containing 1 pseudogene 1) is classified as a *pseudogene*, which is a genomic DNA sequence similar to a regular gene but typically non-functional due to mutations or loss of coding potential. Pseudogenes may arise from gene duplications or retrotransposition events and sometimes retain regulatory elements or sequence similarity to their parent functional genes, potentially influencing them through RNA interference or acting as miRNA decoys. However, there is no specific information or evidence indicating that THSD1P1 has a biological function, disease role, or relevance as a therapeutic target. The closely related **THSD1** gene codes for a protein with roles in cell-matrix interactions and focal adhesion assembly[5], but "THSD1P1" refers specifically to a non-coding pseudogene related to THSD1, and does not code for a functional protein[2][6]. If you meant the protein-coding gene "Thrombospondin type 1 domain containing 1" (THSD1), please clarify, as that is a distinct entity with possible biological and disease relevance[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thrombospondin type 1 domain containing 1 pseudogene 1 (THSD1P1).